L-DIHYDRO-2-OXOQUINOLINFORBINDELSER SOM 5-HT4-RECEPTORLIGANDER

The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention...

Full description

Saved in:
Bibliographic Details
Main Authors MOHAMMED, Abdul, Rasheed, SHINDE, Anil, Karbhari, BHYRAPUNENI, Gopinadh, RAVULA, Jyothsna, AHMAD, Ishtiyaque, NIROGI, Ramakrishna, KANDIKERE, Nagaraj, Vishwottam, KAMBHAMPATI, Rama, Sastri, PATNALA, Sriramachandra, Murthy, JAYARAJAN, Pradeep, JASTI, Venkateswarlu
Format Patent
LanguageDanish
Published 04.07.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The compounds of the present invention are useful in the treatment/prevention of various disorders that are mediated by 5-HT4 receptor activity.
Bibliography:Application Number: DK20090818647T